{"id":393051,"date":"2020-12-03T14:39:31","date_gmt":"2020-12-03T19:39:31","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=393051"},"modified":"2020-12-03T14:39:31","modified_gmt":"2020-12-03T19:39:31","slug":"cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\/","title":{"rendered":"CytoDyn to Hold Webcast on December 10 to Update Clinical and Regulatory Developments"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">VANCOUVER, Washington, Dec.  03, 2020  (GLOBE NEWSWIRE) &#8212; <strong>CytoDyn Inc. (OTC.QB: CYDY)<\/strong>, (\u201cCytoDyn\u201d or the \u201cCompany&#8221;), a late-stage biotechnology company developing Vyrologix\u2122 (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development, and Mahboob Rahman, M.D., Ph.D., Chief Scientific Officer, will host an investment community webcast on Thursday, December 10, 2020.<\/p>\n<p>Management will provide an update on recent clinical and regulatory developments regarding COVID-19 clinical trials, along with other strategic priorities.<\/p>\n<p>Management will also provide approximately 30-45 minutes to address questions submitted online by analysts and investors.<\/p>\n<p>\n        <strong>Date: <\/strong> Thursday, December 10, 2020<br \/><strong>Time:<\/strong> 1:00 pm PT \/ 4:00 pm ET<br \/><strong>Dial<\/strong><strong>&#8211;<\/strong><strong>In:<\/strong> None.<br \/><strong>Questions:<\/strong><\/p>\n<ul type=\"disc\">\n<li>Prior to the webcast, questions can be submitted online to <a href=\"mailto:CYDY_Team@cytodyn.com\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">CYDY_Team@cytodyn.com<\/a><\/li>\n<li>During the webcast, questions can be submitted through the webcast link below.<\/li>\n<\/ul>\n<p>This is a \u201clisten only\u201d webcast, which can be accessed via CytoDyn\u2019s corporate website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=xbsNpohlvoFd8jolIg9yjWskR9j3KVauq3bnSCF0Sx8L412jiYNJTZRNND0FQUgLdNt8c692twPOjRJymLXY3g==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.cytodyn.com<\/a>\u00a0under the Investors section\/IR Calendar and will be archived for 30 days. Participants are encouraged to go to the website 15 minutes prior to the start of the webcast to register, download and install any necessary software. The webcast can also be accessed via the following link:<\/p>\n<p>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=kRgym-BZfu6EbC0gKNxntMpllravyFAmJqCPoPa1T0gKdw4PMdkK63BljW_WSkAlBvsxw2iMuKhu7B-tYR3sv7jAua4O79GECzvTLEJpC1hHYr27oFlMNRbpHbU8lrZGaA2WNujigcm09v7jr7Ln37wNGKNdVsoehFX-5AR8Dop1lA4ylKS83-hyPIBAmlCuNcCjklVF3R5U_D_iMnVE2gB1_phVPfp9ejI46VXntuv6_5J1xOiUQEEIysXZ6or3Ui3PLDFyDyD5HRSXb0JMtQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\"><br \/>\n          <u>https:\/\/78449.themediaframe.com\/dataconf\/productusers\/cydy\/mediaframe\/42454\/indexl.html<\/u><br \/>\n        <\/a>\n      <\/p>\n<p>The replay will be available approximately 60 minutes after the conclusion of the webcast and can be accessed via the above link until January 10, 2021.<\/p>\n<p>\n        <strong>CONTACTS<\/strong><br \/>\n        <br \/>\n        <strong>Investors: <\/strong><br \/>\n        <br \/>Michael Mulholland<br \/>Office: 360.980.8524, ext. 102<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NbzP6VbQEHu9oGuUszv7q-CDStKM2MasYFTAcwzB-BgvUfIzSJfQwkiewoSHAFFzVrhB1cJCtRmgEEAW4mdUxXMMbt9zh8tHBtIXK6E_7ZM=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">mmulholland@cytodyn.com<\/a><\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NjUxMyMzODU1NjY0IzIwMjY1OTg=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/59906b60-974c-4de5-88ef-c052389d7e31\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>VANCOUVER, Washington, Dec. 03, 2020 (GLOBE NEWSWIRE) &#8212; CytoDyn Inc. (OTC.QB: CYDY), (\u201cCytoDyn\u201d or the \u201cCompany&#8221;), a late-stage biotechnology company developing Vyrologix\u2122 (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development, and Mahboob Rahman, M.D., Ph.D., Chief Scientific Officer, will host an investment community webcast on Thursday, December 10, 2020. Management will provide an update on recent clinical and regulatory developments regarding COVID-19 clinical trials, along with other strategic priorities. Management will also provide approximately 30-45 minutes to address questions submitted online by analysts and investors. Date: Thursday, December 10, 2020Time: 1:00 pm PT \/ &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;CytoDyn to Hold Webcast on December 10 to Update Clinical and Regulatory Developments&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-393051","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CytoDyn to Hold Webcast on December 10 to Update Clinical and Regulatory Developments - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CytoDyn to Hold Webcast on December 10 to Update Clinical and Regulatory Developments - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, Washington, Dec. 03, 2020 (GLOBE NEWSWIRE) &#8212; CytoDyn Inc. (OTC.QB: CYDY), (\u201cCytoDyn\u201d or the \u201cCompany&#8221;), a late-stage biotechnology company developing Vyrologix\u2122 (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development, and Mahboob Rahman, M.D., Ph.D., Chief Scientific Officer, will host an investment community webcast on Thursday, December 10, 2020. Management will provide an update on recent clinical and regulatory developments regarding COVID-19 clinical trials, along with other strategic priorities. Management will also provide approximately 30-45 minutes to address questions submitted online by analysts and investors. Date: Thursday, December 10, 2020Time: 1:00 pm PT \/ &hellip; Continue reading &quot;CytoDyn to Hold Webcast on December 10 to Update Clinical and Regulatory Developments&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-03T19:39:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NjUxMyMzODU1NjY0IzIwMjY1OTg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"CytoDyn to Hold Webcast on December 10 to Update Clinical and Regulatory Developments\",\"datePublished\":\"2020-12-03T19:39:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\\\/\"},\"wordCount\":267,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NjUxMyMzODU1NjY0IzIwMjY1OTg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\\\/\",\"name\":\"CytoDyn to Hold Webcast on December 10 to Update Clinical and Regulatory Developments - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NjUxMyMzODU1NjY0IzIwMjY1OTg=\",\"datePublished\":\"2020-12-03T19:39:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NjUxMyMzODU1NjY0IzIwMjY1OTg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODA5NjUxMyMzODU1NjY0IzIwMjY1OTg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CytoDyn to Hold Webcast on December 10 to Update Clinical and Regulatory Developments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CytoDyn to Hold Webcast on December 10 to Update Clinical and Regulatory Developments - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\/","og_locale":"en_US","og_type":"article","og_title":"CytoDyn to Hold Webcast on December 10 to Update Clinical and Regulatory Developments - Market Newsdesk","og_description":"VANCOUVER, Washington, Dec. 03, 2020 (GLOBE NEWSWIRE) &#8212; CytoDyn Inc. (OTC.QB: CYDY), (\u201cCytoDyn\u201d or the \u201cCompany&#8221;), a late-stage biotechnology company developing Vyrologix\u2122 (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today Nader Pourhassan, Ph.D., President and Chief Executive Officer, Scott Kelly, M.D., Chairman, Chief Medical Officer and Head of Business Development, and Mahboob Rahman, M.D., Ph.D., Chief Scientific Officer, will host an investment community webcast on Thursday, December 10, 2020. Management will provide an update on recent clinical and regulatory developments regarding COVID-19 clinical trials, along with other strategic priorities. Management will also provide approximately 30-45 minutes to address questions submitted online by analysts and investors. Date: Thursday, December 10, 2020Time: 1:00 pm PT \/ &hellip; Continue reading \"CytoDyn to Hold Webcast on December 10 to Update Clinical and Regulatory Developments\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-03T19:39:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NjUxMyMzODU1NjY0IzIwMjY1OTg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"CytoDyn to Hold Webcast on December 10 to Update Clinical and Regulatory Developments","datePublished":"2020-12-03T19:39:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\/"},"wordCount":267,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NjUxMyMzODU1NjY0IzIwMjY1OTg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\/","name":"CytoDyn to Hold Webcast on December 10 to Update Clinical and Regulatory Developments - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NjUxMyMzODU1NjY0IzIwMjY1OTg=","datePublished":"2020-12-03T19:39:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NjUxMyMzODU1NjY0IzIwMjY1OTg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODA5NjUxMyMzODU1NjY0IzIwMjY1OTg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/cytodyn-to-hold-webcast-on-december-10-to-update-clinical-and-regulatory-developments\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"CytoDyn to Hold Webcast on December 10 to Update Clinical and Regulatory Developments"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/393051","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=393051"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/393051\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=393051"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=393051"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=393051"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}